{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Radiopaque Tissue Transfer System in Breast-Conserving Surgery"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "The sample size was calculated to detect a 50% reduction in PMR with 80% power at a two-sided \u03b1 level of 0.05."
      },
      "Participants": {
        "score": 2,
        "evidence": "122 patients with microcalcification-associated breast cancer were randomised 1:1 to receive either KliniTray\u2122 or the institutional standard orientation (ISO) procedure."
      },
      "Intervention": {
        "score": 2,
        "evidence": "122 patients with microcalcification-associated breast cancer were randomised 1:1 to receive either KliniTray\u2122 or the institutional standard orientation (ISO) procedure."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial assessed whether a radiopaque tissue transfer and X-ray system (KliniTray\u2122) could reduce the positive margin rate (PMR) in breast-conserving surgery (BCS) for non-palpable breast cancer associated with microcalcifications."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the PMR, measured using final histopathology."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using permutated block randomisation with allocation concealment via closed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "The study was open-label, with no blinding of outcome assessors, patients, or clinicians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Conducted at a single centre, 122 patients with microcalcification-associated breast cancer were randomised 1:1 to receive either KliniTray\u2122 or the institutional standard orientation (ISO) procedure."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Of the 122 randomised, 117 patients were analysed (60 in the KliniTray\u2122 group and 57 in the ISO group) using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The final PMR was 31.7% for KliniTray\u2122 and 26.3% for ISO (P = 0.127). Independent factors for positive margins included histological tumour size >30 mm (adjusted OR 10.73; 95% CI 3.14 to 36.75; P < 0.001) and specimen size >50 mm (adjusted OR 6.65; 95% CI 2.00 to 22.08; P = 0.002)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: DRKS00011527."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}